L469 (Bismuth subsalicylate (chewable) 262 mg)
Pill imprint L469 has been identified as Bismuth subsalicylate (chewable) 262 mg.
Bismuth subsalicylate is used in the treatment of helicobacter pylori infection; diarrhea, chronic; diarrhea; indigestion; lymphocytic colitis (and more), and belongs to the drug class antidiarrheals. FDA has not classified the drug for risk during pregnancy. Bismuth subsalicylate 262 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 262 mg
- Rx and/or OTC
- Drug Class:
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Kroger Company
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium carbonate
Note: Inactive ingredients may vary.
More about bismuth subsalicylate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 12 Reviews – Add your own review/rating
- Drug class: antidiarrheals
- Bismuth subsalicylate
- Bismuth subsalicylate chewable tablets
- Bismuth subsalicylate suspension
- Bismuth subsalicylate (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.